Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

CytoDyn submits IND application to study leronlimab for COVID-19 respiratory complications

March 9, 2020

Arcturus partners with Duke-NUS on COVID-19 vaccine development

March 6, 2020

Il-Yang Pharmaceutical presents new antivirals

March 6, 2020

EpiVax collaborates with University of Georgia and Generex to develop COVID-19 vaccines

March 5, 2020

Takeda begins development of anti-SARS-CoV-2 polyclonal H-IG

March 5, 2020

Nascent Biotech to evaluate the potential of pritumumab as therapy for COVID-19

March 5, 2020

Nanoparticle vaccine elicits HBV therapeutic response

March 4, 2020

anti-SARS CoV antibody CR-3022 shows potent binding to 2019-nCoV spike protein

March 4, 2020

SIGA agrees to provide Tpoxx in support of Turnstone's SKV vaccinia oncolytic immunotherapy program

March 3, 2020

New antibacterials discovered at Recreo Pharmaceuticals

March 3, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...